F161 Case Series of Endophthalmitis After Intravitreal Injection of Counter Fight Bevacizumab

Auffarth, Gerd

F161 Case Series of Endophthalmitis After Intravitreal Injection of Counter Fight Bevacizumab

Friday, April 25, 2014

KIOSKS (Boston Convention and Exhibition Center)

Gerd U. Auffarth, MD, David J Apple International Laboratory for Ocular Pathology and International Vision Correction Research Centre, University of Heidelberg, Heidelberg, Germany

Florian N. Auerbach, MD, University Hospital Heidelberg, Heidelberg, Baden-Wuerttembe, Germany

Florian T. Kretz, MD, University Ophthalmology Hospital, Heidelberg, Germany

Endophthalmitis is a rare complication in intravitreal treatment with anti-VEGF agents. Video presents a case series of 14 eyes (12 patients from northern Iraq) that developed severe endophthalmitis after intravitreal counterfeit bevacizumab injection in Turkey. Eleven eyes had to be enucleated and 3 eyes underwent pars plana vitrectomy in our institution.

Narrative Responses: